Inhibited aortic aneurysm formation in BLT1-deficient mice

Journal of Immunology

Volumn 179, Issue 1, 2007, Pages 691-697

  Ahluwalia, Neil ^a,b   Lin, Alexander Y ^a,b   Tager, Andrew M ^a,b   Pruitt, Ivy E ^a,b   Anderson, Thomas J T ^a,b   Kristo, Fjoralba ^a,b   Shen, Dongxiao ^a,b   Cruz, Anna R ^a,b   Aikawa, Masanori ^a,c   Luster, Andrew D ^a,b   Gerszten, Robert E ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; ARACHIDONATE 5 LIPOXYGENASE; CHEMOATTRACTANT; G PROTEIN COUPLED RECEPTOR; GELATINASE A; GELATINASE B; LEUKOTRIENE; LEUKOTRIENE A4 HYDROLASE; LEUKOTRIENE B4; LIPID; PROTEIN BLT1; UNCLASSIFIED DRUG;

ABDOMINAL AORTA ANEURYSM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL WALL; CELL SUBPOPULATION; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME SYNTHESIS; HUMAN; HUMAN CELL; INCIDENCE; LEUKOCYTE; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR AFFINITY; SIGNAL TRANSDUCTION; SYNTHESIS; VASCULAR DISEASE;

EID: 34250835541     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.179.1.691     Document Type: Article

References (34)

1. Spanbroek, R., R. Grabner, K. Lotzer, M. Hildner, A. Urbach, K. Ruhling, M. P. Moos, B. Kaiser, T. U. Cohnert, T. Wahlers, et al. 2003. Expanding expression of the 5-lipoxygenase pathway within the arterial wall during human atherogenesis. Proc. Natl. Acad. Sci. USA 100: 1238-1243.
2. 4 production in human atherosclerotic plaques. Biomed. Biochim. Acta 47: S182-S185.
3. 4 hydrolase in human atherosclerotic lesions correlates with symptoms of plaque instability. Proc. Natl. Acad. Sci. USA 103: 8161-8166.
4. Dwyer, J. H., H. Allayee, K. M. Dwyer, J. Fan, H. Wu, R. Mar, A. J. Lusis, and M. Mehrabian. 2004. Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis. N. Engl. J. Med. 350: 29-37.
5. 4 hydrolase confers ethnicity-specific risk of myocardial infarction. Nat. Genet. 38: 68-74.
6. Helgadottir, A., A. Manolescu, G. Thorleifsson, S. Gretarsdottir, H. Jonsdottir, U. Thorsteinsdottir, N. J. Samani, G. Gudmundsson, S. F. Grant, G. Thorgeirsson, et al. 2004. The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nat. Genet. 36: 233-239.
7. Gitlin, J. M., D. B. Trivedi, R. Langenbach, and C. D. Loftin. 2007. Genetic deficiency of cyclooxygenase-2 attenuates abdominal aortic aneurysm formation in mice. Cardiovasc. Res. 73: 227-236.
8. Daugherty, A., M. W. Manning, and L. A. Cassis. 2000. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J. Clin. Invest. 105: 1605-1612.
9. Thompson, R. W., P. J. Geraghty, and J. K. Lee. 2002. Abdominal aortic aneurysms: basic mechanisms and clinical implications. Curr. Probl. Surg. 39: 110-230.
10. Zhao, L., M. P. Moos, R. Grabner, F. Pedrono, J. Fan, B. Kaiser, N. John, S. Schmidt, R. Spanbroek, K. Lotzer, et al. 2004. The 5-lipoxygenase pathway promotes pathogenesis of hyperlipidemia-dependent aortic aneurysm. Nat. Med. 10: 966-973.
11. 4. Nat. Med. 8: 1018-1023.
12. 4-induced chemotaxis and adhesion and plays a dominant role in eosinophil accumulation in a murine model of peritonitis. J. Exp. Med. 192: 439-446.
13. Borgeat, P., et. al. 1979. Transformation of arachadonic acid by rabbit polymorphonuclear lymphocytes. J. Biol. Chem. 254: 2643-2646.
14. Ford-Hutchinson, A. W., e. al. 1980. Leukotriene B4, a potent chemokinetic and aggregating substance released from polymorphonuclear lymphocytes. Nature 286: 264-265.
15. Heller, E. A., E. Liu, A. M. Tager, S. Sinha, J. D. Roberts, S. L. Koehn, P. Libby, E. R. Aikawa, J. Q. Chen, P. Huang, et al. 2005. Inhibition of atherogenesis in BLT1-deficient mice reveals a role for LTB4 and BLT1 in smooth muscle cell recruitment. Circulation 112: 578-586.
16. 4 signaling through NF-κB-dependent BLT1 receptors on vascular smooth muscle cells in atherosclerosis and intimal hyperplasia. Proc. Natl. Acad. Sci. USA 102: 17501-17506.
17. 4 receptor, BLT2: a new therapeutic target in inflammation and immunological disorders. J. Exp. Med. 192: 421-432.
18. 4 receptors. Prostaglandins Leukot. Essent Fatty Acids 69: 123-134.
19. 4 receptors in the development of atherosclerosis: potential mechanisms. Arterioscler. Thromb. Vasc. Biol. 24: 369-375.
20. Plump, A. S., J. D. Smith, T. Hayek, K. Aalto-Setala, A. Walsh, J. G. Verstuyft, E. M. Rubin, and J. L. Breslow. 1992. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 71: 343-353.
21. Kuhlencordt, P. J., J. Chen, F. Han, J. Astern, and P. L. Huang. 2001. Genetic deficiency of inducible nitric oxide synthase reduces atherosclerosis and lowers plasma lipid peroxides in apolipoprotein E-knockout mice. Circulation 103: 3099-3104.
22. null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways. Nat. Med. 10: 416-421.
23. Gerszten, R. E., E. B. Friedrich, T. Matsui, R. R. Hung, L. Li, T. Force, and A. Rosenzweig. 2001. Role of phosphoinositide 3-kinase in monocyte recruitment under flow conditions. J. Biol. Chem. 276: 26846-26851.
24. Saraff, K., F. Babamusta, L. A. Cassis, and A. Daugherty. 2003. Aortic dissection precedes formation of aneurysms and atherosclerosis in angiotensin II-infused, apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 23: 1621-1626.
25. Bruemmer, D., A. R. Collins, G. Noh, W. Wang, M. Territo, S. Arias-Magallona, M. C. Fishbein, F. Blaschke, U. Kintscher, K. Graf, R. E. Law, and W. A. Hsueh. 2003. Angiotensin II-accelerated atherosclerosis and aneurysm formation is attenuated in osteopontin-deficient mice. J. Clin. Invest. 112: 1318-1331.
26. 4 strongly increases monocyte chemoattractant protein-1 in human monocytes. Arterioscler. Thromb. Vasc. Biol. 24: 1783-1788.
27. Matsukawa, A., C. M. Hogaboam, N. W. Lukacs, P. M. Lincoln, R. M. Strieter, and S. L. Kunkel. 1999. Endogenous monocyte chemoattractant protein-1 (MCP-1) protects mice in a model of acute septic peritonitis: cross-talk between MCP-1 and leukotriene B4. J. Immunol. 163: 6148-6154.
28. Gerszten, R. E., E. A. Garcia-Zepeda, Y. C. Lim, M. Yoshida, H. A. Ding, M. A. Gimbrone, Jr., A. D. Luster, F. W. Luscinskas, and A. Rosenzweig. 1999. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature 398: 718-723.
29. Longo, G. M., W. Xiong, T. C. Greiner, Y. Zhao, N. Fiotti, and B. T. Baxter. 2002. Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. J. Clin. Invest. 110: 625-632.
30. Rola-Pleszczynski, M., and I. Lemaire. 1985. Leukotrienes augment interleukin 1 production by human monocytes. J. Immunol. 135: 3958-3961.
31. Aiello, R. J., P. A. Bourassa, S. Lindsey, W. Weng, A. Freeman, and H. J. Showell. 2002. Leukotriene B4 receptor antagonism reduces monocytic foam cells in mice. Arterioscler. Thromb. Vasc. Biol. 22: 443-449.
32. Cipollone, F., A. Mezzetti, M. L. Fazia, C. Cuccurullo, A. Iezzi, S. Ucchino, F. Spigonardo, M. Bucci, F. Cuccurullo, S. M. Prescott, and D. M. Stafforini. 2005. Association between 5-lipoxygenase expression and plaque instability in humans. Arterioscler. Thromb. Vasc. Biol. 25: 1665-1670.
33. 4 receptor BLT1 mediates early effector T cell recruitment. Nat Immunol. 4: 982-990.
34. Yoshimura, K., H. Aoki, Y. Ikeda, K. Fujii, N. Akiyama, A. Furutani, Y. Hoshii, N. Tanaka, R. Ricci, T. Ishihara, et al. 2005. Regression of abdominal aortic aneurysm by inhibition of c-Jun N-terminal kinase. Nat. Med. 11: 1330-1338.